FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to endocrinology, and concerns obesity treatment. For this purpose patient suffering from obesity is introduced thioctacide in dose 600 mg daily intravenously by dripping in isotonic solution 10 times. Then said preparation is introduced in tablets in dose 600 mg in the morning 30 minutes before breakfast during 1-2 months. Treatment is carried out against the background of hypocaloric diet.
EFFECT: complex normalisation of weight, hypothalamic disorders, prevention of diabetes and side effects.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES IN PATIENTS WITH METABOLIC SYNDROME | 2010 |
|
RU2438662C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
| METHOD FOR CORRECTION OF ABDOMINAL OBESITY | 2013 |
|
RU2525007C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
| METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
| METHOD OF REHABILITATION OF CHILDREN AND ADOLESCENTS SUFFERING OBESITY | 2010 |
|
RU2440086C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH ALIMENTARY-CONSTITUTIVE OBESITY | 2016 |
|
RU2626147C1 |
| METHOD OF THROMBOCYTE DISTURBANCE LEVELLING IN METABOLIC SYNDROME | 2007 |
|
RU2329040C1 |
| METHOD OF DECREASED THROMBOCYTE ACTIVITY IN PATIENTS SUFFERING FROM METABOLIC SYNDROME | 2007 |
|
RU2345764C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
